Hyperinsulinemia characteristic of obesity and metabolic syndrome exerts direct mitogenic effects on endometrial cells through activation of specific insulin receptors identified in both normal endometrial tissue and malignant cells, triggering robust phosphorylation of insulin receptor substrate (IRS) proteins and subsequent PI3K/AKT pathway activation. The gene discussed is AKT1; the disease is Hyperinsulinemia.